Characterization of Short-Lived Electrophilic Metabolites of the Anticancer Agent Laromustine (VNP40101M)
Authors:
- 1 March 2011
- journal article
- research article
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 24 (4) , 568-578
Abstract
Laromustine (VNP40101M; 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino) carbonylhydrazine) is a novel sulfonylhydrazine alkylating agent. Phase 1 metabolism of laromustine was reported recently and showed that laromustine undergoes rearrangement, dehalogenation, and hydrolysis at physiological pH to form active moieties. (1) A mechanism for the rearrangement was proposed on the basis of fragmentation ions. (1), (2) In this article, we report the phase II conjugates of VNP40101M and VNP4090CE which were formed after incubation of VNP40101M or VNP4090CE with pooled human liver microsomes (HLM) and cofactors nicotinamide adenine dinucleotide phosphate (NADPH), glutathione (GSH), N-acetylecysteine (NAC), and cysteine (CYS). Eight novel phase II conjugates (M-1 to M-8) were identified and characterized by hydrogen−deuterium exchange (H-D), stable isotope (13C-labeled VNP40101M), and MSn experiments. M-4 and M-5 were further confirmed by nuclear magnetic resonance spectroscopy (NMR). The short-lived CH3SO2CH2CH2−, methylformamide and CH3SO2NHN═CHCH2− moieties were generated from VNP40101M. The reactive intermediates CH3SO2CH2CH2− and methylformamide formed conjugates with GSH, CYS, and NAC. The CH3SO2NHN═CHCH2− moiety formed conjugates with GSH and NAC. M-2, M-4, and M-6 were only detected from the incubation of VNP40101M because VNP4090CE does not contain a methylformamide group. All other conjugates were formed by both VNP40101M and VNP4090CE. The in vitro studies found that VNP40101M and VNP4090CE undergo activation in human liver microsomes. The results from this study showed that laromustine produces several reactive intermediates that may play a role in the toxicities seen in the clinical trials.Keywords
This publication has 15 references indexed in Scilit:
- Case Study: The Unanticipated Loss of N2from Novel DNA Alkylating Agent Laromustine by Collision‐Induced Dissociation: Novel Rearrangements2010
- Regulation of isocyanate-induced apoptosis, oxidative stress, and inflammation in cultured human neutrophilsCell Biology and Toxicology, 2009
- Isocyanates induces DNA damage, apoptosis, oxidative stress, and inflammation in cultured human lymphocytesJournal of Biochemical and Molecular Toxicology, 2008
- 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (VNP40101M): I. Direct inhibition of O 6 -alkylguanine-DNA alkyltransferase (AGT) by electrophilic species generated by decompositionCancer Chemotherapy and Pharmacology, 2004
- Strategies for dealing with metabolite elucidation in drug discovery and developmentDrug Discovery Today, 2004
- Online Hydrogen-Deuterium Exchange and a Tandem-Quadrupole Time-of-Flight Mass Spectrometer Coupled with Liquid Chromatography for Metabolite Identification in Drug MetabolismJournal of Chromatographic Science, 2003
- Advances in the application of mass spectrometry to studies of drug metabolism, pharmacokinetics and toxicologyInternational Journal of Mass Spectrometry and Ion Processes, 1992
- Drug Metabolism by Leukocytes and Its Role in Drug-Induced Lupus and Other Idiosyncratic Drug ReactionsCritical Reviews in Toxicology, 1990
- Evaluating the potential for genotoxic carcinogenicity of methyl isocyanateToxicology and Applied Pharmacology, 1987
- The toxicity of methyl isocyanate: Where do we stand?Environmental Health Perspectives, 1987